Polar Securities »

Ani Pharmaceuticals shares owned by Polar Securities

Quarter-by-quarter ownership of Ani Pharmaceuticals shares owned by Polar Securities from 13F filings

Historical chart of Polar Securities investment in Ani Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Ani Pharmaceuticals held by Polar Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ani Pharmaceuticals by Polar Securities

Quarter filed Position value Share count Share price at filing
2025-09-30 $8.4M 6.0M 1.41

More positions owned by Polar Securities

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Sprott Asset Management Physical Gold Tr (PHYS)
Interdigital Note 3.500% 6/0 (Principal)
Live Nation Entertainment In Note 3.125% 1/1 (Principal)
NVIDIA Corporation (NVDA)
Home Depot (HD)
Axon Enterprise Note 0.500%12/1 (Principal)
Granite Constr Note 3.750% 5/1 (Principal)
Apple (AAPL)
Verona Pharma Sponsored Ads (VRNA)
Broadcom (AVGO)
Itron Note 1.375% 7/1 (Principal)
Tesla Motors (TSLA)
Arista Networks Com Shs (ANET)

View all positions for Polar Securities

Top funds holding Ani Pharmaceuticals

Linden Advisors
Camden Asset Management
BlackRock
Empyrean Capital Partners
Millennium Management
Citadel Advisors
Absolute Investment Advisers
Jpmorgan Chase & Co
Lazard Asset Management
Polar Securities
Gabelli Funds
Leucadia National Corporation
Universal- Beteiligungs- und Servicegesellschaft mbH
Picton Mahoney Asset Management
FMR

View all funds holding Ani Pharmaceuticals